Physician profile
Charles E Leonard
NPI 1811971963
$1,041.43
in general payments reported to CMS, 2019-2025
23 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.00 · 2022: $16.59 · 2023: $172 · 2024: $409 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $148.91 | 2024 | Illuccix |
| Exelixis INC. | $131.74 | 2023-2024 | Cabometyx |
| Sumitomo Pharma America, INC. | $73.60 | 2025 | Orgovyx |
| Tersera Therapeutics LLC | $62.67 | 2023-2024 | Xermelo |
| Janssen Biotech, INC. | $60.18 | 2024-2025 | Tecvayli, Talvey, Darzalex |
| Daiichi Sankyo INC. | $58.58 | 2024 | Enhertu, Vanflyta |
| Seagen INC. | $47.16 | 2023 | Padcev, Adcetris |
| Bayer Healthcare Pharmaceuticals INC. | $43.40 | 2024-2025 | |
| Pfizer INC. | $42.42 | 2024-2025 | |
| Genzyme Corporation | $37.73 | 2024 | |
| Novartis Pharmaceuticals Corporation | $37.50 | 2025 | |
| Aveo Pharmaceuticals, INC. | $34.86 | 2025 | |
| Novocure INC. | $30.22 | 2025 | Optune Gio |
| Abbvie INC. | $29.39 | 2025 | |
| Azurity Pharmaceuticals, INC. | $28.72 | 2025 | Danziten |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $26.03 | 2024 | |
| Sobi, INC | $25.79 | 2025 | |
| Lilly USA, LLC | $25.60 | 2025 | Verzenio, Jaypirca |
| Puma Biotechnology, INC. | $25.00 | 2025 | |
| Astellas Pharma US INC | $22.14 | 2025 | Padcev |
| Genentech USA, INC. | $20.20 | 2025 | Polivy |
| Tactile Systems Technology INC | $16.59 | 2022 | |
| Tosoh Bioscience, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.